Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

237 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Ten years of HPV vaccination in the Netherlands: current evidence and future challenges in HPV-related disease prevention.
Qendri V, Schurink-Van 't Klooster TM, Bogaards JA, Berkhof J. Qendri V, et al. Expert Rev Vaccines. 2018 Dec;17(12):1093-1104. doi: 10.1080/14760584.2018.1547196. Epub 2018 Nov 29. Expert Rev Vaccines. 2018. PMID: 30417704 Review.
HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3.
Zielinski GD, Rozendaal L, Voorhorst FJ, Berkhof J, Snijders PJ, Risse EJ, Runsink AP, de Schipper FA, Meijer CJ. Zielinski GD, et al. Gynecol Oncol. 2003 Oct;91(1):67-73. doi: 10.1016/s0090-8258(03)00415-3. Gynecol Oncol. 2003. PMID: 14529664
HPV type concordance in sexual couples determines the effect of condoms on regression of flat penile lesions.
Bleeker MC, Berkhof J, Hogewoning CJ, Voorhorst FJ, van den Brule AJ, Starink TM, Snijders PJ, Meijer CJ. Bleeker MC, et al. Br J Cancer. 2005 Apr 25;92(8):1388-92. doi: 10.1038/sj.bjc.6602524. Br J Cancer. 2005. PMID: 15812547 Free PMC article.
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands.
Bulk S, Berkhof J, Bulkmans NW, Zielinski GD, Rozendaal L, van Kemenade FJ, Snijders PJ, Meijer CJ. Bulk S, et al. Br J Cancer. 2006 Jan 16;94(1):171-5. doi: 10.1038/sj.bjc.6602915. Br J Cancer. 2006. PMID: 16404371 Free PMC article.
High-risk HPV type-specific clearance rates in cervical screening.
Bulkmans NW, Berkhof J, Bulk S, Bleeker MC, van Kemenade FJ, Rozendaal L, Snijders PJ, Meijer CJ; POBASCAM Study Group. Bulkmans NW, et al. Br J Cancer. 2007 May 7;96(9):1419-24. doi: 10.1038/sj.bjc.6603653. Epub 2007 Mar 6. Br J Cancer. 2007. PMID: 17342094 Free PMC article.
High-risk human papillomavirus is present in cytologically false-negative smears: an analysis of "normal" smears preceding CIN2/3.
Bulk S, Rozendaal L, Zielinski GD, Berkhof J, Daalmeijer NC, Snijders PJ, van Kemenade FJ, Meijer CJ. Bulk S, et al. J Clin Pathol. 2008 Mar;61(3):385-9. doi: 10.1136/jcp.2006.045948. Epub 2007 Aug 3. J Clin Pathol. 2008. PMID: 17675539
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial.
Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJ, Bulk S, Voorhorst FJ, Verheijen RH, van Groningen K, Boon ME, Ruitinga W, van Ballegooijen M, Snijders PJ, Meijer CJ. Bulkmans NW, et al. Lancet. 2007 Nov 24;370(9601):1764-72. doi: 10.1016/S0140-6736(07)61450-0. Epub 2007 Oct 4. Lancet. 2007. PMID: 17919718 Clinical Trial.
Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening.
Coupé VM, Berkhof J, Bulkmans NW, Snijders PJ, Meijer CJ. Coupé VM, et al. Br J Cancer. 2008 Feb 12;98(3):646-51. doi: 10.1038/sj.bjc.6604162. Epub 2008 Jan 8. Br J Cancer. 2008. PMID: 18182990 Free PMC article.
[Vaccines against human papillomavirus (HPV); between registration and implementation].
van Rossum TG, de Melker HE, Houweling H, Voordouw AC, Meijer CJ, Helmerhorst TJ, Kretzschmar M, Berkhof J, van der Noordaa J. van Rossum TG, et al. Ned Tijdschr Geneeskd. 2008 Apr 26;152(17):987-92. Ned Tijdschr Geneeskd. 2008. PMID: 18549172 Review. Dutch.
237 results
Jump to page